Literature DB >> 16884788

Antiviral activity of Arthrospira-derived spirulan-like substances.

Sabine Rechter1, Tanja König, Sabrina Auerochs, Stefanie Thulke, Hauke Walter, Heike Dörnenburg, Christian Walter, Manfred Marschall.   

Abstract

Natural substances offer interesting pharmacological perspectives for antiviral drug development in regard to broad-spectrum antiviral properties and novel modes of action. In this study we analyzed polysaccharide fractions isolated from Arthrospira platensis. Fractions containing intracellular or extracellular spirulan-like molecules showed a pronounced antiviral activity in the absence of cytotoxic effects. Using specific assays for the quantification of viral replication in vitro, these substances exhibited strong inhibition of human cytomegalovirus, herpes simplex virus type 1, human herpesvirus type 6 and human immunodeficiency virus type 1, while only weak or no inhibition was noted for Epstein-Barr virus and influenza A virus. Considering herpesviruses, antiviral effects were most pronounced when the cells were preincubated with the substances prior to the addition of virus, indicating that antiviral action may be primarily targeted to virus entry. However, an inspection of the inhibition of human cytomegalovirus protein synthesis clearly demonstrated that intracellular steps also contributed to the antiviral effect. In the case of human immunodeficiency virus, inhibition occurred at a stage later than viral entry. Thus, spirulan-like substances possess a marked antiherpesviral and anti-HIVactivity based on different modes of action. Further development of these substances might yield novel candidates of broad-spectrum antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884788     DOI: 10.1016/j.antiviral.2006.06.004

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  30 in total

1.  A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.

Authors:  Corina Hutterer; Jan Eickhoff; Jens Milbradt; Klaus Korn; Isabel Zeitträger; Hanife Bahsi; Sabrina Wagner; Gunther Zischinsky; Alexander Wolf; Carsten Degenhart; Anke Unger; Matthias Baumann; Bert Klebl; Manfred Marschall
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

2.  In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses.

Authors:  Manfred Marschall; Thomas Stamminger; Andreas Urban; Steffen Wildum; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

3.  Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells.

Authors:  Yih-Yih Kok; Wan-Loy Chu; Siew-Moi Phang; Shar Mariam Mohamed; Rakesh Naidu; Pey-Jiun Lai; Shui-Nyuk Ling; Joon-Wah Mak; Patricia Kim-Chooi Lim; Pauline Balraj; Alan Soo-Beng Khoo
Journal:  J Zhejiang Univ Sci B       Date:  2011-05       Impact factor: 3.066

4.  Human embryonic lung fibroblasts treated with artesunate exhibit reduced rates of proliferation and human cytomegalovirus infection in vitro.

Authors:  Ai-Hong Zeng; Yang-Ying Ou; Ming-Ming Guo; Xuan Dai; De-Zhi Zhou; Rui Chen
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

5.  Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.

Authors:  Anna Luganini; Patrizia Caposio; Santo Landolfo; Giorgio Gribaudo
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

Review 6.  Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2009-03-19

7.  Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.

Authors:  Daman Reynolds; Michael Huesemann; Scott Edmundson; Amy Sims; Brett Hurst; Sherry Cady; Nathan Beirne; Jacob Freeman; Adam Berger; Song Gao
Journal:  Algal Res       Date:  2021-05-18       Impact factor: 4.401

8.  Pluronic F127-tailored lecithin organogel of acyclovir: preclinical evidence of antiviral activity using BALB/c murine model of cutaneous HSV-1 infection.

Authors:  Gajanand Sharma; Bimaldeep Kaur; Kanika Thakur; Akanksha Mahajan; Basant Amarji; Mini P Singh; Om Prakash Katare
Journal:  Drug Deliv Transl Res       Date:  2021-01-23       Impact factor: 4.617

Review 9.  Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications.

Authors:  Shaden A M Khalifa; Eslam S Shedid; Essa M Saied; Amir Reza Jassbi; Fatemeh H Jamebozorgi; Mostafa E Rateb; Ming Du; Mohamed M Abdel-Daim; Guo-Yin Kai; Montaser A M Al-Hammady; Jianbo Xiao; Zhiming Guo; Hesham R El-Seedi
Journal:  Mar Drugs       Date:  2021-04-24       Impact factor: 5.118

10.  The effect of Arthrospira platensis capsules on CD4 T-cells and antioxidative capacity in a randomized pilot study of adult women infected with human immunodeficiency virus not under HAART in Yaoundé, Cameroon.

Authors:  Frank Stéphane Winter; Francois Emakam; Anfumbom Kfutwah; Johannes Hermann; Marcel Azabji-Kenfack; Michael B Krawinkel
Journal:  Nutrients       Date:  2014-07-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.